Posted on 7/8/20
Foghorn Therapeutics Announces Collaboration with Merck
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foghorn Therapeutics Inc., a company advancing an unprecedented class of therapeutics targeting the chromatin regulatory system in oncology, announced that it has entered into . . .
Posted on 7/8/20
SCL Health Partners with Kyruus
BROOMFIELD, Colo. & BOSTON--(BUSINESS WIRE)--Kyruus, the leader in provider search and scheduling solutions for health systems, and SCL Health, a faith-based nonprofit health system providing care . . .
Posted on 7/8/20
Therapeutics Acquisition Prices Upsized $118M IPO
BOSTON--(BUSINESS WIRE)--Therapeutics Acquisition Corp. announced today that it priced its initial public offering of 11,800,000 shares of Class A common stock at $10.00 per share. The . . .
Posted on 7/8/20
Inozyme Pharma Begins U.S. IPO Effort
SummaryInozyme Pharma has filed to raise $86 million in a U.S. IPO.The firm is developing treatments for abnormal calcification diseases.INZY has produced promising preclinical testing results . . .
Posted on 7/7/20
Acceleron Closes Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (Nasdaq: XLRN), a leading biopharmaceutical company in the discovery, development, and commercialization of TGF-beta superfamily therapeutics to treat serious and rare . . .
Posted on 7/7/20
Bioasis Announces Stock Option Grants
GUILFORD, Conn.--(BUSINESS WIRE)--BIOASIS TECHNOLOGIES INC. (TSXV:BTI.V; OTCQB:BIOAF), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 platform technology for the delivery of therapeutics across the blood-brain . . .
Posted on 7/7/20
Editas Medicine and Azzur Group Announce a Multi-year Agreement
Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, and Azzur Cleanrooms on Demand (COD), an Azzur Group company, today announced the companies have entered a . . .
Posted on 7/7/20
Pear Therapeutics Announces $50 Million Credit Facility
BOSTON & SAN FRANCISCO--(BUSINESS WIRE)--Pear Therapeutics, Inc. today announced that it closed a credit facility for up to $50 million from Perceptive Advisors, a leading life . . .
Posted on 7/7/20
Tonix Pharmaceuticals Plans Massachusetts R&D Facility
NEW YORK, July 07, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced its intent . . .
Posted on 7/7/20
Vor Biopharma Raises $110M In Series B
Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, today announced it has raised $110 million in a Series . . .
Posted on 7/7/20
CVS: Aetna Can Deliver Better Health
SummaryGiven the overall American healthcare landscape, CVS Aetna is well positioned to participate in some of the best segments with lower risk.Aetna has been posting strong . . .
Posted on 7/7/20
Alexion Pharmaceuticals Agrees to $21.5 Million Settlement With SEC in Bribery Case
Alexion Pharmaceuticals (NASDAQ:ALXN) is reaching into its coffers to settle charges leveled against it by the Securities and Exchange Commission. The company will hand over a . . .
Posted on 7/6/20
Dragonfly Therapeutics Announces New Research Collaboration with Bristol Myers Squibb
Dragonfly Therapeutics, Inc., today announced a new research collaboration with Bristol Myers Squibb to discover and develop Dragonfly's novel immunotherapies for multiple sclerosis and neuro-inflammation targets.Under . . .
Posted on 7/6/20
Unum Therapeutics Acquires Kiq
Unum Therapeutics Inc. (NASDAQ: UMRX), a biopharmaceutical company focused on developing therapies for solid tumors, today announced it has completed the acquisition of Kiq LLC
Posted on 7/6/20
Bristol-Myers Squibb: Growth And Valuation Trump Other Concerns
SummaryWhile the Celgene acquisition added blockbusters to the company’s product portfolio, it comes with big debt and integration risk.Bristol’s top three drugs provide 69% of revenues.The . . .
Posted on 7/6/20
Sarepta Therapeutics Signs Agreement with Hansa Biopharma for Imlifidase
CAMBRIDGE, Mass., July 02, 2020 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced an agreement with . . .
Posted on 7/6/20
Chiasma Proposes Public Offering of Common Stock
NEEDHAM, Mass., (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial biopharmaceutical company focused on developing and commercializing oral therapies utilizing its proprietary Transient Permeability Enhancer . . .
Posted on 7/2/20
Diversified Healthcare Trust Amends Credit and Term Loan Agreements and Provides COVID Related Business Updates
NEWTON, Mass.--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) today announced that it has amended the agreements governing its $1 billion unsecured revolving credit facility and $200 million . . .
Posted on 7/2/20
Forget Vertex, Biogen Is a Better Value Stock
Among pharmaceutical industry investors, Vertex Pharmaceuticals (NASDAQ:VRTX) is a broadly popular stock thanks to its impressive year-over-year quarterly earnings growth of 124.4% and its proven history . . .
Posted on 7/13/20
BIOMODEX Announces Results Of First Clinical Study
BIOMODEX®, a pioneering digital health company that offers a unique and enhanced 3D printed solution for patient-specific rehearsal and physician training, today announced the results of . . .
Posted on 7/1/20
Amylyx Pharmaceuticals Raises $30 Million in Series B Funding
Amylyx Pharmaceuticals, Inc., a pharmaceutical company focused on developing new treatments for amyotrophic lateral sclerosis (ALS), Alzheimer’s disease and other neurodegenerative diseases,
Posted on 7/1/20
Philips Ranked as World’s Most Innovative Medtech Company in Boston Consulting Group’s Annual Report
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the company has earned a place on Boston Consulting . . .
Posted on 7/1/20
Sumitomo Dainippon Pharma Oncology Announces Its Formation Through Merger of Tolero and Boston Biomedical
Sumitomo Dainippon Pharma Oncology, Inc. was formed today through the merger of Tolero Pharmaceuticals, Inc., and Boston Biomedical, Inc., two clinical-stage companies developing novel cancer therapeutics . . .
Posted on 7/1/20
KalVista Pharmaceuticals Provides Operational Update
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease . . .
Posted on 7/1/20
Sherlock Biosciences and Binx Health Announce Global Partnership
CAMBRIDGE, Mass. & BOSTON--(BUSINESS WIRE)--Sherlock Biosciences and binx health today announced the companies have entered into a strategic partnership to develop the world’s first rapid, point-of-care . . .
Boston
